XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.23.1

STOCKHOLDERS' EQUITY | 3 Months Ended
--- | ---
Mar. 31, 2023
Equity [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Stockholders’ Equity The following tables present the changes in stockholders’ equity (in millions):
| Three Months Ended March 31, 2023
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 350.0 |  |  | $ | 0.4 |  |  | $ | 7,703.9 |  |  | $ | 3,500.1 |  |  | $ | (162.5) |  |  | $ | 11,041.9 |  |  | $ | 70.7 |  |  | $ | 11,112.6 |
Issuance of common stock through employee stock plans | 2.4 |  |  | — |  |  | 100.2 |  |  | — |  |  | — |  |  | 100.2 |  |  | — |  |  | 100.2 |
Shares withheld related to net share settlement of equity awards | (0.5) |  |  | — |  |  | (5.9) |  |  | (123.8) |  |  | — |  |  | (129.7) |  |  | — |  |  | (129.7) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 146.0 |  |  | — |  |  | — |  |  | 146.0 |  |  | — |  |  | 146.0 |
Repurchase and retirement of common stock | (1.5) |  |  | — |  |  | (15.8) |  |  | (334.2) |  |  | — |  |  | (350.0) |  |  | — |  |  | (350.0) |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 355.3 |  |  | — |  |  | 355.3 |  |  | — |  |  | 355.3 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | 54.0 |  |  | 54.0 |  |  | 0.3 |  |  | 54.3 |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5.5 |  |  | 5.5 |
Ending balance | 350.4 |  |  | $ | 0.4 |  |  | $ | 7,928.4 |  |  | $ | 3,397.4 |  |  | $ | (108.5) |  |  | $ | 11,217.7 |  |  | $ | 76.5 |  |  | $ | 11,294.2 |
| Three Months Ended March 31, 2022
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 357.7 |  |  | $ | 0.4 |  |  | $ | 7,164.0 |  |  | $ | 4,760.9 |  |  | $ | (24.2) |  |  | $ | 11,901.1 |  |  | $ | 50.4 |  |  | $ | 11,951.5 |
Issuance of common stock through employee stock plans | 2.2 |  |  | — |  |  | 80.0 |  |  | — |  |  | — |  |  | 80.0 |  |  | — |  |  | 80.0 |
Shares withheld related to net share settlement of equity awards | (0.6) |  |  | — |  |  | (6.1) |  |  | (166.1) |  |  | — |  |  | (172.2) |  |  | — |  |  | (172.2) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 120.8 |  |  | — |  |  | — |  |  | 120.8 |  |  | — |  |  | 120.8 |
Repurchase and retirement of common stock | (0.4) |  |  | — |  |  | (4.1) |  |  | (102.4) |  |  | — |  |  | (106.5) |  |  | — |  |  | (106.5) |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 365.6 |  |  | — |  |  | 365.6 |  |  | — |  |  | 365.6 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | (86.5) |  |  | (86.5) |  |  | 0.4 |  |  | (86.1) |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3.8 |  |  | 3.8 |
Ending balance | 358.9 |  |  | $ | 0.4 |  |  | $ | 7,354.6 |  |  | $ | 4,858.0 |  |  | $ | (110.7) |  |  | $ | 12,102.3 |  |  | $ | 54.6 |  |  | $ | 12,156.9 |
Stock Repurchase Program The Company’s Board of Directors (the “Board”) has authorized an aggregate of $10.0 billion of funding for the Company’s common stock repurchase program (the “Repurchase Program”) since its establishment in March 2009. The most recent authorization occurred in July 2022, when the Board increased the authorized amount available under the Repurchase Program to $3.5 billion, including amounts remaining under previous authorization. As of March 31, 2023, the remaining amount of share repurchases authorized by the Board under the Repurchase Program was approximately $1.1 billion. The following table summarizes stock repurchase activities (in millions, except per share amounts):
| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Shares repurchased | 1.5 |  |  | 0.4 |  |  |  |  |
Average price per share | $ | 238.1 |  |  | $ | 268.0 |  |  |  |  |
Value of shares repurchased | $ | 350.0 |  |  | $ | 106.5 |  |  |  |  |
As a provision of the Inflation Reduction Act enacted in the U.S. during 2022, the Company is subject to an excise tax on corporate stock repurchases, which is assessed as one percent of the fair market value of net stock repurchases after December 31, 2022. For the three months ended March 31, 2023, no excise tax was accrued, as the aggregate fair market value of the Company’s stock issuances exceeded the fair market value of stock repurchases. , Net of Tax, Attributable to Intuitive Surgical, Inc. The components of accumulated other comprehensive loss, net of tax, attributable to Intuitive Surgical, Inc. are as follows (in millions):
| Three Months Ended March 31, 2023
| Gains (Losses) on Hedge Instruments |  | Unrealized Gains (Losses) on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | (2.9) |  |  | $ | (154.2) |  |  | $ | (6.6) |  |  | $ | 1.2 |  |  | $ | (162.5) |
Other comprehensive income (loss) before reclassifications | 3.7 |  |  | 37.8 |  |  | 13.9 |  |  | — |  |  | 55.4 |
Amounts reclassified from accumulated other comprehensive income (loss) | (1.2) |  |  | (0.2) |  |  | — |  |  | — |  |  | (1.4) |
Net current-period other comprehensive income (loss) | 2.5 |  |  | 37.6 |  |  | 13.9 |  |  | — |  |  | 54.0 |
Ending balance | $ | (0.4) |  |  | $ | (116.6) |  |  | $ | 7.3 |  |  | $ | 1.2 |  |  | $ | (108.5) |
| Three Months Ended March 31, 2022
| Gains (Losses) on Hedge Instruments |  | Unrealized Gains (Losses) on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | 4.5 |  |  | $ | (16.0) |  |  | $ | (7.9) |  |  | $ | (4.8) |  |  | $ | (24.2) |
Other comprehensive income (loss) before reclassifications | 3.7 |  |  | (90.8) |  |  | 3.1 |  |  | — |  |  | (84.0) |
Amounts reclassified from accumulated other comprehensive income (loss) | (2.7) |  |  | 0.1 |  |  | — |  |  | 0.1 |  |  | (2.5) |
Net current-period other comprehensive income (loss) | 1.0 |  |  | (90.7) |  |  | 3.1 |  |  | 0.1 |  |  | (86.5) |
Ending balance | $ | 5.5 |  |  | $ | (106.7) |  |  | $ | (4.8) |  |  | $ | (4.7) |  |  | $ | (110.7) |
The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications were as follows (in millions):
| Three Months Ended March 31, |  |
Available-for-sale securities | 2023 |  | 2022 |  |  |  |
Income tax benefit (expense) for net gains (losses) recorded in other comprehensive income (loss) | $ | (10.9) |  |  | $ | 29.7 |  |  |  |  |
The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications for hedge instruments, foreign currency translation, and employee benefit plans for the three months ended March 31, 2023, and 2022, were not material to the Company’s Financial Statements. The tax impacts for amounts reclassified from accumulated other comprehensive loss relating to hedge instruments, available-for-sale securities, foreign currency translation, and employee benefit plans for the three months ended March 31, 2023, and 2022, were not material to the Company’s Financial Statements.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration